Deep Brain Stimulation Market Share Revenue and Growth Rate to Increase During Forecast Year 2020-2030
Market Overview
Deep brain stimulation is a surgery that involves implanting a device that transmits a signal to the parts of the brain that control movement. DBS helps to alleviate the symptoms of stiffness, sluggishness, and walking difficulties caused by neurological illnesses such dystonia, Parkinson's disease, and essential tremor. Patients who have not responded to medications for at least five years might consider this treatment. Furthermore, the FDA has authorized this medication for individuals who are unable to undergo epilepsy surgery, which involves separating or removing the region of the brain that causes seizures. As a result, the increased frequency of neurological diseases such as Alzheimer's and Parkinson's disease is a primary driver of market expansion.
Deep Brain Stimulation Market: Key Players
Abbott (St. Jude Medical)
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Medtronic
Boston Scientific Corporation
Aleva Neurotherapeutics S.A.
Nexstim
LivaNova PLC
Neuropace Inc.
Renishaw PLC
Beijing PINS Medical Co. Ltd
Fisher Wallace
Growth Factor
Rapidly aging population
According to the Globe Ageing 2019 study, there were around 703 million people aged 65 and up in the world in 2019. In 2050, this population is expected to increase to 1.5 billion. Furthermore, by 2050, one in every six individuals on the planet will be beyond the age of 65, up from one in every eleven in 2019. The older population is expected to grow, and this group is more susceptible to neurological problems, which will drive the market in the near future.
Segmentation
By Stimulation Type
Subthalamic DBS
Globus Pallidus DBS
Thalamic DBS
Pedunculopontine Nucleus DBS
By Product
Single Channel Deep Brain Stimulator
Dual Channel Deep Brain Stimulator
By Application
Parkinson's Disease (PD)
Epilepsy
Dystonia
Obsessive Compulsive Disorder (OCD)
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Neurological Centers
Others
Deep Brain Stimulation Market Dynamics
Deep Brain Stimulation Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
In February 2019, Medtronic announced the availability of Deep Brain Simulation (DBS) in the United States for medically resistant epilepsy. Such a unique offering will help the firm expand its consumer base and increase income.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Deep Brain Stimulation Market growth?
Which segment accounted for the largest Deep Brain Stimulation Market share?
Who are the key players in the Deep Brain Stimulation Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Deep brain stimulation is a surgery that involves implanting a device that transmits a signal to the parts of the brain that control movement. DBS helps to alleviate the symptoms of stiffness, sluggishness, and walking difficulties caused by neurological illnesses such dystonia, Parkinson's disease, and essential tremor. Patients who have not responded to medications for at least five years might consider this treatment. Furthermore, the FDA has authorized this medication for individuals who are unable to undergo epilepsy surgery, which involves separating or removing the region of the brain that causes seizures. As a result, the increased frequency of neurological diseases such as Alzheimer's and Parkinson's disease is a primary driver of market expansion.
Deep Brain Stimulation Market: Key Players
Abbott (St. Jude Medical)
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Medtronic
Boston Scientific Corporation
Aleva Neurotherapeutics S.A.
Nexstim
LivaNova PLC
Neuropace Inc.
Renishaw PLC
Beijing PINS Medical Co. Ltd
Fisher Wallace
Growth Factor
Rapidly aging population
According to the Globe Ageing 2019 study, there were around 703 million people aged 65 and up in the world in 2019. In 2050, this population is expected to increase to 1.5 billion. Furthermore, by 2050, one in every six individuals on the planet will be beyond the age of 65, up from one in every eleven in 2019. The older population is expected to grow, and this group is more susceptible to neurological problems, which will drive the market in the near future.
Segmentation
By Stimulation Type
Subthalamic DBS
Globus Pallidus DBS
Thalamic DBS
Pedunculopontine Nucleus DBS
By Product
Single Channel Deep Brain Stimulator
Dual Channel Deep Brain Stimulator
By Application
Parkinson's Disease (PD)
Epilepsy
Dystonia
Obsessive Compulsive Disorder (OCD)
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Neurological Centers
Others
Deep Brain Stimulation Market Dynamics
Deep Brain Stimulation Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
In February 2019, Medtronic announced the availability of Deep Brain Simulation (DBS) in the United States for medically resistant epilepsy. Such a unique offering will help the firm expand its consumer base and increase income.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Deep Brain Stimulation Market growth?
Which segment accounted for the largest Deep Brain Stimulation Market share?
Who are the key players in the Deep Brain Stimulation Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. EXECUTIVE SUMMARY
2. GLOBAL DEEP BRAIN STIMULATION MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL DEEP BRAIN STIMULATION MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL DEEP BRAIN STIMULATION MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL DEEP BRAIN STIMULATION MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia, Thailand, Malaysia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Argentina, Colombia, Chile and Venezuela), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. MEA: (South Africa, Saudi Arabia, UAE, Turkey and Iran), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Stimulation Type: Market Share (2020-2030F)
12.2.1. Subthalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Globus Pallidus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Thalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Pedunculopontine Nucleus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Product: Market Share (2020-2030F)
12.3.1. Single Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Dual Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Application: Market Share (2020-2030F)
12.4.1. Parkinson's Disease (PD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Epilepsy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Dystonia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Obsessive Compulsive Disorder (OCD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End-User: Market Share (2020-2030F)
12.5.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Ambulatory Surgical Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Neurological Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Medtronic
13.3. Boston Scientific Corporation
13.4. Aleva Neurotherapeutics S.A.
13.5. Nexstim
13.6. LivaNova PLC
13.7. Neuropace Inc.
13.8. Renishaw PLC
13.9. Beijing PINS Medical Co. Ltd
13.10. Fisher Wallace
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL DEEP BRAIN STIMULATION MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL DEEP BRAIN STIMULATION MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL DEEP BRAIN STIMULATION MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL DEEP BRAIN STIMULATION MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia, Thailand, Malaysia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Argentina, Colombia, Chile and Venezuela), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. MEA: (South Africa, Saudi Arabia, UAE, Turkey and Iran), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Stimulation Type: Market Share (2020-2030F)
12.2.1. Subthalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Globus Pallidus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Thalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Pedunculopontine Nucleus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Product: Market Share (2020-2030F)
12.3.1. Single Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Dual Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Application: Market Share (2020-2030F)
12.4.1. Parkinson's Disease (PD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Epilepsy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Dystonia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Obsessive Compulsive Disorder (OCD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End-User: Market Share (2020-2030F)
12.5.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Ambulatory Surgical Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Neurological Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Medtronic
13.3. Boston Scientific Corporation
13.4. Aleva Neurotherapeutics S.A.
13.5. Nexstim
13.6. LivaNova PLC
13.7. Neuropace Inc.
13.8. Renishaw PLC
13.9. Beijing PINS Medical Co. Ltd
13.10. Fisher Wallace
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
